Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-13
DOI
10.3389/fcell.2022.927118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression
- (2022) Yu Miao et al. EBioMedicine
- Genetic layout of melanoma lesions associates to BRAF/MEK-targeted therapy resistance and to transcriptional profiles
- (2022) Elisabetta Vergani et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations
- (2021) Serena Stamatakos et al. Cancers
- Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
- (2021) Rosa Vona et al. Frontiers in Cell and Developmental Biology
- Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
- (2021) Yunshu Gao et al. Frontiers in Oncology
- Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
- (2021) Claudio Vernieri et al. Cancer Discovery
- Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
- (2021) Arwa Alkaraki et al. Cancers
- Lipid composition of the cancer cell membrane
- (2020) Wojciech Szlasa et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
- (2020) Gretchen M. Alicea et al. Cancer Discovery
- Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339
- (2020) Yidan Luo et al. BIOMEDICINE & PHARMACOTHERAPY
- The lipogenic regulator SREBF2 induces Transferrin in circulating melanoma cells and suppresses ferroptosis
- (2020) Xin Hong et al. Cancer Discovery
- A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors
- (2019) Andrea Aloia et al. CLINICAL CANCER RESEARCH
- Dealing with saturated and unsaturated fatty acid metabolism for anticancer therapy
- (2019) Emeline Dierge et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity
- (2019) Yurena Vivas-García et al. MOLECULAR CELL
- Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells
- (2019) Teresa Delgado-Goñi et al. BRITISH JOURNAL OF CANCER
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
- (2019) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
- (2018) Jeffrey E. Gershenwald et al. ANNALS OF SURGICAL ONCOLOGY
- Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
- (2018) Ali Talebi et al. Nature Communications
- Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
- (2018) Maomao Zhang et al. Cancer Discovery
- Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries
- (2018) L. Kandolf Sekulovic et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
- (2018) Maria Elena Pisanu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the sphingosine 1-phosphate axis exerts potent antitumor activity in BRAFi-resistant melanomas
- (2018) David Garandeau et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer
- (2018) Nicholas Theodosakis et al. Pigment Cell & Melanoma Research
- Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
- (2018) Sunilkumar Kakadia et al. OncoTargets and Therapy
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
- (2017) Vasanthi S. Viswanathan et al. NATURE
- Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
- (2017) Grant M. Fischer et al. Pigment Cell & Melanoma Research
- Adipocyte Exosomes Promote Melanoma Aggressiveness through Fatty Acid Oxidation: A Novel Mechanism Linking Obesity and Cancer
- (2016) Ikrame Lazar et al. CANCER RESEARCH
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- Avasimibe Encapsulated in Human Serum Albumin Blocks Cholesterol Esterification for Selective Cancer Treatment
- (2015) Steve Seung-Young Lee et al. ACS Nano
- Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators
- (2015) Maximillian A. Rogers et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
- (2015) Jenny E Hernandez-Davies et al. Journal of Translational Medicine
- Molecular drivers of cellular metabolic reprogramming in melanoma
- (2015) Cecilie Abildgaard et al. TRENDS IN MOLECULAR MEDICINE
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification
- (2015) Matteo Dugo et al. Oncotarget
- Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032
- (2015) Elisabetta Vergani et al. NEOPLASIA
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Acyl-coenzyme A: Cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines
- (2010) Sana Bemlih et al. CANCER BIOLOGY & THERAPY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started